Please assess the completion status of the following clinical trial:

Trial Title: Mortality Reduction in Septic Shock by Plasma Adsorption

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* all patients admitted to the ICU in septic shock~* all patients that develop septic shock while in the ICU~Exclusion Criteria:~* Age less than 18 years~* Pregnancy~* Estimated life expectancy (due to comorbidities) less than 90 days~* Presence of relative or absolute contraindications to CPFA~* Absence of informed consen

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- High doses CPFA (Type: EXPERIMENTAL): High doses CPFA (coupled plasma-filtration adsorption) with AMPLYA™ (BELLCO ITALY): \>0.20 L/kg/day of plasma treated in the first 3 days after randomization
- Control Group (Type: NO_INTERVENTION): Standard practice

Based on this trial design, predict the completion outcome and termination type (if applicable).